Presentations
- Welcome and charge to the group
- Molecular Diagnostics and the Quest for Clinical Utility
- Evolution of Translational Omics: Lessons Learned and the Path Forward
- NCI Workshop: Defining Clinical Utility of Molecular Diagnostics for Cancer Treatment
- Development of a Pharmacogenetic Predictor "CYP2D6 for Tamoxifen"
- Clinical Utility: Lessons from Oncotype DX in Breast, Colon, and Prostate
- Opportunities and Challenges in Translating Novel Discoveries into Useful Clinical Tests
- Reports for Breakouts 1A & 1B: Predictive Biomarkers
- Reports for Breakout Sessions 2A and 2B - Disease Classifiers & Prognostic Assays
- Reports for Breakout Sessions 3A and 3B - Report of assays for monitoring disease status
